missing translation for 'onlineSavingsMsg'
Learn More
Please login to your online account to display your discounted pricing

Amyloid beta A4 Polyclonal Antibody, Invitrogen™

Amyloid beta A4 Antibody, OSA00050G, from Invitrogen™. Species Reactivity: Human, Mouse, Rat; Applications: Immunohistochemistry, Western Blot.

Manufacturer:  Pierce Biotechnology Inc OSA00050G

Catalog No. PIOSA00050G


 

Specifications

Description

Amyloid beta A4 Antibody, OSA00050G, from Invitrogen. Species Reactivity: Human, Mouse, Rat; Applications: Immunohistochemistry, Western Blot.


Host Species: Rabbit
Cross Reactivity: Human, Mouse, Rat
Isotype: IgG
Immunogen: A synthetic peptide from aa region 400-450 of human APP conjugated to an immunogenic carrier protein
Formulation: 500μg purified antibody (1mg/mL) and no preservative
Synonyms: Alzheimer disease amyloid A4 protein homolog, ABPP, APP, Amyloidogenic glycoprotein, AG, Amyloid beta A4 protein, amyloid beta (A4) precursor protein, AAA, AD1, PN2, ABPP, APPI, CVAP, ABETA, CTF gamma, Peptidase nexin-II, Alzheimer disease
Uniprot Accession: P05067, P08592, P12023
Entrez GeneID: 11820, 351, 54226
Gene Symbol: APP
Reconstitute with 500 ul of distilled water.
Description & Specifications

Specifications

Amyloid beta A4
Unlabeled
500μg purified antibody (1mg/mL) and no preservative
Alzheimer disease amyloid A4 protein homolog, ABPP, APP, Amyloidogenic glycoprotein, AG, Amyloid beta A4 protein, amyloid beta (A4) precursor protein, AAA, AD1, PN2, ABPP, APPI, CVAP, ABETA, CTF gamma, Peptidase nexin-II, Alzheimer disease
Rabbit
IgG
avoiding freeze/thaw cycles.
Polyclonal
Human,Murine,Rat
Immunohistochemistry,Western Blot
Purified
P05067, P08592, P12023
APP
A synthetic peptide from aa region 400-450 of human APP conjugated to an immunogenic carrier protein
500μg
Primary
11820, 351, 54226
Promotions

Promotions

  • Purchase any three Invitrogen™ Antibodies and receive a fourth antibody at no additional cost. This is an NLSU exclusive offer. You must apply and qualify for the program to be eligible.

    06/30/18